REMISSION OF METASTASES OF ERYTHROPOIETIN-SECRETING RENAL CELL ADENOCARCINOMA AFTER 6-MERCAPTOPURINE (NSC-755)-1 THERAPY.
D000230:Adenocarcinoma; D001772:Blood Cell Count; D002292:Carcinoma, Renal Cell; D000068817:Epoetin Alfa; D004921:Erythropoietin; D005853:Geriatrics; D006801:Humans; D007680:Kidney Neoplasms; D008175:Lung Neoplasms; D015122:Mercaptopurine; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000532:radiotherapy*; D016609:Neoplasms, Second Primary; D009392:Nephrectomy
D004921:Erythropoietin; D000068817:Epoetin Alfa; D015122:Mercaptopurine
ADENOCARCINOMA; BLOOD CELL COUNT; ERYTHROPOIETIN; GERIATRICS; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MERCAPTOPURINE; NEOPLASM METASTASIS; NEOPLASM RADIOTHERAPY; NEPHRECTOMY